Insider Shareholders with Direct Ownership of Concert Pharmaceuticals, Inc. (CNCE)
This section provides a comprehensive overview of the insiders with direct ownership of Concert Pharmaceuticals, Inc. (CNCE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CONCERT PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Roger D Tung
Chief Executive Officer |
284,900 | 880,983 | 971,018 $0 | 11 |
Jan 06, 2023
Reduced 0.94%
|
|
Richard Aldrich
Director |
21,525 | 358,500 | 358,500 $0 | 3 |
Jun 09, 2022
Added 4.37%
|
|
Bvf Partners L P
> 10% Shareholder |
331,916 | 1,669,145 | 169,589 $0 | 3 |
Jun 10, 2019
Reduced 14.8%
|
|
Ronald W Barrett
Director |
5,125 | 0 | 5,125 $0 | 1 |
Jun 10, 2021
Added 50.0%
|
|
Peter Barton Hutt
Director |
25,064 | 33,027 | 0 $0 | 5 |
Mar 06, 2023
Reduced 100.0%
|
|
Nancy Stuart
Chief Operating Officer |
142,100 | 278,329 | 0 $0 | 9 |
Mar 06, 2023
Reduced 100.0%
|
|
Jeffrey A Munsie
Chief Legal Officer |
85,400 | 113,616 | 0 $0 | 9 |
Mar 06, 2023
Reduced 100.0%
|
|
James V Cassella
Chief Development Officer |
132,200 | 173,627 | 0 $0 | 10 |
Mar 06, 2023
Reduced 100.0%
|
|
Marc A. Becker
Chief Financial Officer |
103,300 | 138,834 | 0 $0 | 10 |
Mar 06, 2023
Reduced 100.0%
|
|
Wilfred E Jaeger
Director |
21,525 | 21,525 | 0 $0 | 3 |
Mar 06, 2023
Reduced 100.0%
|
|
Christi Van Heek
Director |
32,051 | 42,051 | 0 $0 | 4 |
Mar 06, 2023
Reduced 100.0%
|
|
Jesper Hoeiland
Director |
21,525 | 21,525 | 0 $0 | 3 |
Mar 06, 2023
Reduced 100.0%
|
|
Thomas G Auchincloss
Director |
27,525 | 34,025 | 0 $0 | 4 |
Mar 06, 2023
Reduced 100.0%
|